戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 the anti-inflammatory activity of human i.v. immunoglobulin therapy.
2 eresis (PPH) in conjunction with intravenous immunoglobulin therapy.
3 uble-blind, placebo-controlled trials of RSV immunoglobulin therapy.
4 e illness may be ameliorated by passive oral immunoglobulin therapy.
5 taminated, open wounds with immunization and immunoglobulin therapy.
6 f response to corticosteroid and intravenous immunoglobulin therapy, a 3-day course of plasmapheresis
7 Group 1 and 2 patients received no hepatitis immunoglobulin therapy after transplantation and receive
8                 He also received intravenous immunoglobulin therapy and his vision has stabilized.
9 d on novel therapeutic interventions such as immunoglobulin therapy and immunosuppressive therapy in
10 analysis of anti-Hbs elimination can improve immunoglobulin therapy and prevent recurrence of clinica
11 f juvenile rheumatoid arthritis, intravenous immunoglobulin therapy appeared ineffective in the disea
12 imen using plasmapheresis and/or intravenous immunoglobulin therapy, but underlying mechanisms that c
13  must be in some doubt, although intravenous immunoglobulin therapy has been shown to be beneficial i
14           The anemia promptly remitted after immunoglobulin therapy in 3 of 4 treated patients.
15  November 2002 to November 2004, intravenous immunoglobulin therapy (IVIG) was administered to patien
16 an update of the evidence-based guideline on immunoglobulin therapy, last published in 2006.
17 gy in 80 patients established (>6 months) on immunoglobulin therapy; prospective analysis of HBV sero
18 atory properties associated with intravenous immunoglobulin therapy require the sialic acid modificat
19          With increasing patient survival on immunoglobulin therapy, there is an increasing focus on
20   In response to the 2014 outbreak, an ovine immunoglobulin therapy was developed, termed EBOTAb.
21 nd controversial indications for intravenous immunoglobulin therapy, with special emphasis on its mec

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。